Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 12, 2022
The U.S. Pharmacopeia (USP) announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a suite of R&D analytical solutions.
read more
Monday, December 12, 2022
Solon, OH: CMC Pharmaceuticals has been awarded a Sequential Phase II Small Business Innovation Research (“SBIR”) grant from the U.S. Defense Department’s (“DoD”) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear ...
read more
Thursday, December 15, 2022
PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2).
read more
Friday, December 16, 2022
AGC Biologics announced a collaboration with W.L. Gore & Associates that features Protein A affinity purification technology from Gore alongside the CDMO’s contract development and manufacturing services.
read more
Friday, December 16, 2022
Catalent announced that it is to establish a new biologics analytical center of excellence in Durham, within North Carolina’s Research Triangle, to offer comprehensive standalone analytical development and testing for biologic drug modalities, ...
read more
Friday, December 16, 2022
Clariant is set to expand its Care Chemicals facility in Daya Bay, Huizhou, China, to boost its support for pharmaceutical, personal care, home care, and industrial application customers.
The CHF 80 million investment will see capacity increases for...
read more
Friday, December 16, 2022
Kindeva Drug Delivery and Meridian Medical Technologies announced the completion of the transaction to combine the two companies
read more
Friday, December 16, 2022
Syneos Health® announced it has extended its strategic partnership with Medable as part of the Company’s commitment to bring clinical trials closer to the patient.
read more
Friday, December 16, 2022
CluePoints, announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds Co-Founder, Francois Torche, who is stepping back as CEO to focus his full attention on the strategic direction of CluePoints’ world-leading ...
read more
Monday, December 19, 2022
Formulated Solutions announced an agreement to acquire a newly updated 455,000 ft2 FDA approved pharmaceutical liquids, semi solids, aerosol, BoV, and metered dose nasal spray production facility located in Cleveland, TN.
read more
Tuesday, December 20, 2022
Scorpion Biological Services has changed its name to Scorpius BioManufacturing to reflect the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October.
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies...
read more
Tuesday, December 20, 2022
The U.S. District Court for the Western District of Oklahoma entered a consent decree against Qualgen LLC, an outsourcing facility with a history of violations.
read more
Wednesday, January 04, 2023
MA–Nova Biomedical is pleased to announce the launch of BioProfile FAST CDVTM, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100uL of sample volume. In ...
read more
Thursday, January 05, 2023
Biognosys AG and Bruker Corporation announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed.
read more